article Editorial. (2023). The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor. Union of pediatricians of Russia.
Chicago Style (17th ed.) Citationarticle Editorial. The FDA Has Expanded the Indications for the Appointment of an Oral Janus Kinase 1 Inhibitor. Union of pediatricians of Russia, 2023.
MLA (9th ed.) Citationarticle Editorial. The FDA Has Expanded the Indications for the Appointment of an Oral Janus Kinase 1 Inhibitor. Union of pediatricians of Russia, 2023.
Warning: These citations may not always be 100% accurate.